title: Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fascitis caused by Apophysomyces elegans.
authors: Department of Clinical Microbiology, Pondicherry Institute of Medical Sciences, Pondicherry, India. sheeladevic@yahoo.com
authors: Sheela C
authors: SC
authors: Devi
authors: Reba
authors: R
authors: Kanungo
authors: Elvino
authors: E
authors: Barreto
authors: Abraham G
authors: AG
authors: Thomas
authors: Nair
authors: N
authors: Shashikala
authors: S
authors: S
authors: Srinivasan
authors: Patricia K
authors: PK
authors: Anitha
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003646:Debridement; D019115:Fasciitis, Necrotizing / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009090:Mucorales / Q000254:growth & development / Q000302:isolation & purification*; D009091:Mucormycosis / Q000188:drug therapy* / Q000601:surgery; D016038:Skin Transplantation; D014946:Wound Infection
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B